Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nxstage Medical, Inc. (NXTM) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nxstage Medical, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1333170.
Total stock buying since 2014: $304,017.
Total stock sales since 2014: $26,085,467.
Total stock option exercises since 2014: $17,444,213.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 0 | $0 | 7,000 | $172,760 | 141,837 | $1,583,127 |
| 2017 | 0 | $0 | 389,810 | $10,535,084 | 414,000 | $4,868,801 |
| 2016 | 21,000 | $304,017 | 128,211 | $2,985,931 | 215,358 | $2,269,079 |
| 2015 | 0 | $0 | 365,096 | $6,553,466 | 436,498 | $2,345,175 |
| 2014 | 0 | $0 | 371,035 | $5,838,226 | 728,112 | $6,378,031 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-05 | 0 | $0 | 0 | $0 | 59,980 | $842,632 |
| 2018-03 | 0 | $0 | 0 | $0 | 75,857 | $674,315 |
| 2018-02 | 0 | $0 | 3,500 | $85,680 | 3,000 | $33,090 |
| 2018-01 | 0 | $0 | 3,500 | $87,080 | 3,000 | $33,090 |
| 2017-12 | 0 | $0 | 3,500 | $88,725 | 28,369 | $348,553 |
| 2017-11 | 0 | $0 | 3,500 | $90,055 | 3,000 | $33,090 |
| 2017-10 | 0 | $0 | 8,530 | $234,635 | 7,030 | $89,711 |
| 2017-09 | 0 | $0 | 8,800 | $240,656 | 25,496 | $340,970 |
| 2017-08 | 0 | $0 | 39,800 | $1,129,481 | 38,300 | $547,275 |
| 2017-07 | 0 | $0 | 8,800 | $213,638 | 7,300 | $93,505 |
| 2017-06 | 0 | $0 | 11,050 | $257,954 | 9,550 | $135,332 |
| 2017-05 | 0 | $0 | 5,550 | $127,695 | 4,550 | $65,062 |
| 2017-04 | 0 | $0 | 29,197 | $783,634 | 22,799 | $357,007 |
| 2017-03 | 0 | $0 | 34,413 | $953,699 | 105,016 | $622,525 |
| 2017-02 | 0 | $0 | 122,767 | $3,371,309 | 98,290 | $1,513,556 |
| 2017-01 | 0 | $0 | 113,903 | $3,043,603 | 64,300 | $722,215 |
| 2016-12 | 0 | $0 | 23,800 | $609,220 | 7,300 | $93,505 |
| 2016-11 | 0 | $0 | 64,418 | $1,660,112 | 64,516 | $889,317 |
| 2016-09 | 0 | $0 | 3,000 | $69,930 | 0 | $0 |
| 2016-08 | 0 | $0 | 0 | $0 | 15,272 | $228,927 |
| 2016-05 | 0 | $0 | 2,557 | $45,861 | 50,057 | $919,477 |
| 2016-04 | 0 | $0 | 7,000 | $106,460 | 1,619 | $16,125 |
| 2016-03 | 0 | $0 | 6,380 | $97,127 | 66,178 | $9,960 |
| 2016-02 | 21,000 | $304,017 | 5,991 | $96,798 | 2,611 | $18,226 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-05-21 | Turk Joseph E Jr (President) | Option Ex | 5,392 | 18.59 | 100,237 |
| 2018-05-17 | Giannini Daniel A | Option Ex | 18,196 | 13.60 | 247,465 |
| 2018-05-17 | Reid Perper | Option Ex | 18,196 | 13.60 | 247,465 |
| 2018-05-16 | Moore Craig W | Option Ex | 18,196 | 13.60 | 247,465 |
| 2018-03-14 | Burbank Jeffrey H (Chief Executive Officer) | Option Ex | 36,273 | 18.59 | 674,315 |
| 2018-03-09 | Burbank Jeffrey H (Chief Executive Officer) | Option Ex | 17,464 | .00 | 0 |
| 2018-03-09 | Swan Winifred L (SVP and General Counsel) | Option Ex | 4,657 | .00 | 0 |
| 2018-03-09 | Turk Joseph E Jr (President) | Option Ex | 11,642 | .00 | 0 |
| 2018-03-09 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 5,821 | .00 | 0 |
| 2018-02-20 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 24.48 | 85,680 |
| 2018-02-20 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2018-01-16 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 24.88 | 87,080 |
| 2018-01-16 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-12-20 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 25.35 | 88,725 |
| 2017-12-20 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-12-12 | Funari Robert G | Option Ex | 25,369 | 12.44 | 315,463 |
| 2017-11-15 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 25.73 | 90,055 |
| 2017-11-15 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-10-20 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 27.50 | 96,250 |
| 2017-10-20 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-10-20 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,030 | 27.50 | 110,825 |
| 2017-10-20 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,030 | 14.05 | 56,621 |
| 2017-10-04 | Turk Joseph E Jr (President) | Sale | 1,000 | 27.56 | 27,560 |
| 2017-09-20 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 27.27 | 95,445 |
| 2017-09-20 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-09-20 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 27.27 | 117,261 |
| 2017-09-20 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-09-12 | Mixer Jean K | Option Ex | 18,196 | 13.60 | 247,465 |
| 2017-09-05 | Turk Joseph E Jr (President) | Sale | 1,000 | 27.95 | 27,950 |
| 2017-08-21 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 29.22 | 125,646 |
| 2017-08-21 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-08-15 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 29.21 | 102,235 |
| 2017-08-15 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-08-10 | Turk Joseph E Jr (President) | Sale | 1,000 | 29.26 | 29,260 |
| 2017-08-07 | Turk Joseph E Jr (President) | Sale | 24,000 | 29.64 | 711,480 |
| 2017-08-07 | Turk Joseph E Jr (President) | Option Ex | 24,000 | 15.69 | 376,560 |
| 2017-08-03 | Turk Joseph E Jr (President) | Sale | 7,000 | 22.98 | 160,860 |
| 2017-08-03 | Turk Joseph E Jr (President) | Option Ex | 7,000 | 11.03 | 77,210 |
| 2017-07-20 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 24.16 | 84,560 |
| 2017-07-20 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-07-20 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 24.16 | 103,888 |
| 2017-07-20 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-07-05 | Turk Joseph E Jr (President) | Sale | 1,000 | 25.19 | 25,190 |
| 2017-06-20 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 23.29 | 100,147 |
| 2017-06-20 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-06-15 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 23.14 | 80,990 |
| 2017-06-15 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-06-14 | Turk Joseph E Jr (President) | Sale | 1,000 | 23.74 | 23,740 |
| 2017-06-08 | Turk Joseph E Jr (President) | Sale | 2,250 | 23.59 | 53,077 |
| 2017-06-08 | Turk Joseph E Jr (President) | Option Ex | 2,250 | 18.59 | 41,827 |
| 2017-05-22 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 21.36 | 91,848 |
| 2017-05-22 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-05-10 | Turk Joseph E Jr (President) | Sale | 250 | 23.59 | 5,897 |
| 2017-05-10 | Turk Joseph E Jr (President) | Option Ex | 250 | 18.59 | 4,647 |
| 2017-05-03 | Turk Joseph E Jr (President) | Sale | 1,000 | 29.95 | 29,950 |
| 2017-04-20 | Donigan Heyward R | Option Ex | 3,582 | 21.73 | 77,836 |
| 2017-04-20 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 3,000 | 27.28 | 81,840 |
| 2017-04-20 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 27.28 | 95,480 |
| 2017-04-20 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-04-20 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 27.28 | 117,304 |
| 2017-04-20 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-04-19 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 3,000 | 26.65 | 79,950 |
| 2017-04-13 | Turk Joseph E Jr (President) | Sale | 1,000 | 26.10 | 26,100 |
| 2017-04-03 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 14,397 | 26.60 | 382,960 |
| 2017-04-03 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 11,917 | 15.58 | 185,666 |
| 2017-03-22 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 3,000 | 27.42 | 82,260 |
| 2017-03-21 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 3,000 | 27.72 | 83,160 |
| 2017-03-20 | Swan Winifred L (SVP and General Counsel) | Sale | 15,723 | 27.66 | 434,898 |
| 2017-03-20 | Swan Winifred L (SVP and General Counsel) | Option Ex | 15,223 | 18.59 | 282,995 |
| 2017-03-20 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 27.66 | 118,938 |
| 2017-03-20 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-03-16 | Moore Craig W | Sale | 1,000 | 27.93 | 27,930 |
| 2017-03-10 | Reid Perper | Option Ex | 15,272 | 14.99 | 228,927 |
| 2017-03-08 | Turk Joseph E Jr (President) | Sale | 1,000 | 27.53 | 27,530 |
| 2017-03-06 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 6,390 | 28.01 | 178,983 |
| 2017-03-03 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 9,747 | .00 | 0 |
| 2017-03-03 | Burbank Jeffrey H (Chief Executive Officer) | Option Ex | 28,022 | .00 | 0 |
| 2017-03-03 | Swan Winifred L (SVP and General Counsel) | Option Ex | 7,919 | .00 | 0 |
| 2017-03-03 | Turk Joseph E Jr (President) | Option Ex | 9,747 | .00 | 0 |
| 2017-03-03 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 9,747 | .00 | 0 |
| 2017-03-01 | Turk Joseph E Jr (President) | Option Ex | 5,039 | 9.96 | 50,188 |
| 2017-02-23 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 7,500 | 28.97 | 217,275 |
| 2017-02-22 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 7,500 | 29.01 | 217,575 |
| 2017-02-21 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 29.26 | 125,818 |
| 2017-02-21 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-02-17 | Turk Joseph E Jr (President) | Sale | 6,000 | 29.66 | 177,960 |
| 2017-02-17 | Turk Joseph E Jr (President) | Option Ex | 6,000 | 14.66 | 87,960 |
| 2017-02-15 | Swan Winifred L (SVP and General Counsel) | Sale | 16,049 | 28.01 | 449,532 |
| 2017-02-15 | Swan Winifred L (SVP and General Counsel) | Option Ex | 15,549 | 18.48 | 287,345 |
| 2017-02-14 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 2,448 | 28.28 | 69,229 |
| 2017-02-10 | Turk Joseph E Jr (President) | Sale | 2,500 | 28.59 | 71,475 |
| 2017-02-10 | Turk Joseph E Jr (President) | Option Ex | 2,500 | 18.59 | 46,475 |
| 2017-02-09 | Turk Joseph E Jr (President) | Sale | 1,000 | 27.77 | 27,770 |
| 2017-02-08 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 3,054 | 27.61 | 84,320 |
| 2017-02-07 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 3,117 | 27.54 | 85,842 |
| 2017-02-06 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 3,283 | 27.29 | 89,593 |
| 2017-02-03 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 13,000 | 26.77 | 348,010 |
| 2017-02-03 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 13,000 | 14.66 | 190,580 |
| 2017-02-02 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 17,745 | 26.72 | 474,146 |
| 2017-02-02 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 13,000 | 14.66 | 190,580 |
| 2017-02-02 | Turk Joseph E Jr (President) | Sale | 15,669 | 26.19 | 410,371 |
| 2017-02-02 | Turk Joseph E Jr (President) | Option Ex | 15,669 | 14.72 | 230,694 |
| 2017-02-01 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 19,602 | 26.65 | 522,393 |
| 2017-02-01 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 13,000 | 14.66 | 190,580 |
| 2017-02-01 | Moore Craig W | Option Ex | 15,272 | 14.99 | 228,927 |
| 2017-01-26 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 7,000 | 26.25 | 183,750 |
| 2017-01-26 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 7,000 | 11.03 | 77,210 |
| 2017-01-25 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 20,000 | 26.13 | 522,600 |
| 2017-01-25 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 20,000 | 11.03 | 220,600 |
| 2017-01-24 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 15,000 | 25.86 | 387,900 |
| 2017-01-24 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 15,000 | 11.03 | 165,450 |
| 2017-01-23 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 15,000 | 25.74 | 386,100 |
| 2017-01-23 | Brown Robert S. (President, NxStage Kidney Care) | Option Ex | 15,000 | 11.03 | 165,450 |
| 2017-01-20 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 26.19 | 91,665 |
| 2017-01-20 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2017-01-20 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 26.19 | 112,617 |
| 2017-01-20 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2017-01-19 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 6,615 | 27.57 | 182,375 |
| 2017-01-18 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 8,183 | 27.58 | 225,687 |
| 2017-01-18 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 7,500 | 27.63 | 207,225 |
| 2017-01-17 | Brown Robert S. (President, NxStage Kidney Care) | Sale | 10,805 | 27.72 | 299,514 |
| 2017-01-17 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 7,500 | 27.52 | 206,400 |
| 2017-01-13 | Turk Joseph E Jr (President) | Sale | 7,500 | 28.00 | 210,000 |
| 2017-01-11 | Turk Joseph E Jr (President) | Sale | 1,000 | 27.77 | 27,770 |
| 2016-12-20 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 25.55 | 109,865 |
| 2016-12-20 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2016-12-15 | Swan Winifred L (SVP and General Counsel) | Sale | 3,500 | 25.91 | 90,685 |
| 2016-12-15 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2016-12-14 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 7,500 | 25.68 | 192,600 |
| 2016-12-13 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 7,500 | 25.42 | 190,650 |
| 2016-12-13 | Turk Joseph E Jr (President) | Sale | 1,000 | 25.42 | 25,420 |
| 2016-11-28 | Turk Joseph E Jr (President) | Sale | 2,669 | 26.48 | 70,675 |
| 2016-11-28 | Turk Joseph E Jr (President) | Option Ex | 2,669 | 18.48 | 49,323 |
| 2016-11-25 | Turk Joseph E Jr (President) | Sale | 9,500 | 25.73 | 244,482 |
| 2016-11-25 | Turk Joseph E Jr (President) | Option Ex | 9,500 | 14.81 | 140,695 |
| 2016-11-23 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 7,500 | 24.01 | 180,075 |
| 2016-11-22 | Burbank Jeffrey H (Chief Executive Officer) | Sale | 7,500 | 25.51 | 191,325 |
| 2016-11-22 | Swan Winifred L (SVP and General Counsel) | Sale | 3,000 | 25.51 | 76,530 |
| 2016-11-22 | Swan Winifred L (SVP and General Counsel) | Option Ex | 3,000 | 11.03 | 33,090 |
| 2016-11-21 | Giannini Daniel A | Sale | 6,449 | 25.96 | 167,416 |
| 2016-11-21 | Towse Matthew W (SVP and Chief Financial Office) | Sale | 4,300 | 26.23 | 112,789 |
| 2016-11-21 | Towse Matthew W (SVP and Chief Financial Office) | Option Ex | 4,300 | 14.05 | 60,415 |
| 2016-11-17 | Turk Joseph E Jr (President) | Sale | 1,000 | 25.97 | 25,970 |
| 2016-11-16 | Turk Joseph E Jr (President) | Sale | 22,500 | 26.26 | 590,850 |
| 2016-11-14 | Mixer Jean K | Option Ex | 11,579 | 11.00 | 127,369 |
| 2016-11-02 | Lewis Earl R | Option Ex | 33,468 | 14.29 | 478,425 |
| 2016-09-14 | Moore Craig W | Sale | 1,500 | 23.60 | 35,400 |
| 2016-09-12 | Moore Craig W | Sale | 1,500 | 23.02 | 34,530 |
| 2016-08-04 | Giannini Daniel A | Option Ex | 15,272 | 14.99 | 228,927 |
| 2016-05-25 | Giannini Daniel A | Option Ex | 14,000 | 18.55 | 259,700 |
Insider trading activities including stock purchases, stock sales, and option exercises of NXTM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nxstage Medical, Inc. (symbol NXTM, CIK number 1333170) see the Securities and Exchange Commission (SEC) website.